> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA, LUNGevity Foundation Patient Experience Study
- URL: https://www.fdaweb.com/fda-lungevity-foundation-patient-experience-study/
- Published: 2020-08-27T12:00:00.000Z
- Updated: 2026-09-14T16:26:46.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5147534

The FDA Oncology Center of Excellence and the LUNGevity Foundation have launched a multi-year longitudinal study to understand the lung cancer patient experience, irrespective of diagnosis (stage/histology), outside of the clinical setting. Project PEER (Understanding the Lung Cancer Patient Experience in the Real-World Setting) seeks to systematically understand how patients with lung cancer feel and function and whether this experience is affected by their specific diagnosis and treatment, according to a foundation [statement](https://www.marketwatch.com/press-release/lungevity-launches-lung-cancer-patient-research-project-in-collaboration-with-the-fda-2020-08-27?tesla=y&ref=fdaweb.com).

The statement says the Project PEER real-world data will be used to explore patterns in patient experiences and compare those patterns to what is seen in clinical trial data within the same patient population.